Retained Earnings (Accumulated Deficit) of Odyssey Health, Inc. from 31 Jul 2014 to 31 Jan 2026

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Odyssey Health, Inc. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Jul 2014 to 31 Jan 2026.
  • Odyssey Health, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending 31 Jan 2026 was $66,830,907, a 7.4% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Odyssey Health, Inc. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $66,830,907 -$4,588,729 -7.4% 31 Jan 2026 10-Q 12 Mar 2026 2026 Q2
Q3 2025 $63,229,284 -$1,207,232 -1.9% 31 Oct 2025 10-Q 11 Dec 2025 2026 Q1
Q2 2025 $62,745,837 -$1,742,691 -2.9% 31 Jul 2025 10-Q 12 Mar 2026 2026 Q2
Q1 2025 $62,493,921 -$14,230,281 -29% 30 Apr 2025 10-Q 13 Jun 2025 2025 Q3
Q4 2024 $62,242,178 -$14,820,879 -31% 31 Jan 2025 10-Q 14 Mar 2025 2025 Q2
Q3 2024 $62,022,052 -$1,386,642 -2.3% 31 Oct 2024 10-Q 16 Dec 2024 2025 Q1
Q2 2024 $61,003,146 -$905,771 -1.5% 31 Jul 2024 10-K 29 Oct 2025 2025 FY
Q1 2024 $48,263,640 +$11,019,726 +19% 30 Apr 2024 10-Q 14 Jun 2024 2024 Q3
Q4 2023 $47,421,299 +$10,577,963 +18% 31 Jan 2024 10-Q 22 Mar 2024 2024 Q2
Q3 2023 $60,635,410 -$4,307,876 -7.6% 31 Oct 2023 10-Q 15 Dec 2023 2024 Q1
Q2 2023 $60,097,375 -$5,919,421 -11% 31 Jul 2023 10-K 13 Nov 2024 2024 FY
Q1 2023 $59,283,366 -$7,111,285 -14% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q3
Q4 2022 $57,999,262 -$8,926,452 -18% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q2
Q3 2022 $56,327,534 -$8,947,437 -19% 31 Oct 2022 10-Q 14 Dec 2022 2023 Q1
Q2 2022 $54,177,954 -$8,444,131 -18% 31 Jul 2022 10-K 30 Oct 2023 2023 FY
Q1 2022 $52,172,081 -$9,338,849 -22% 30 Apr 2022 10-Q 14 Jun 2022 2022 Q3
Q4 2021 $49,072,810 -$18,641,268 -61% 31 Jan 2022 10-Q 15 Mar 2022 2022 Q2
Q3 2021 $47,380,097 -$17,817,855 -60% 31 Oct 2021 10-Q 10 Dec 2021 2022 Q1
Q2 2021 $45,733,823 -$16,883,095 -59% 31 Jul 2021 10-K 31 Oct 2022 2022 FY
Q1 2021 $42,833,232 -$15,314,528 -56% 30 Apr 2021 10-Q 21 Jun 2021 2021 Q3
Q4 2020 $30,431,542 -$3,912,112 -15% 31 Jan 2021 10-Q 11 Mar 2021 2021 Q2
Q3 2020 $29,562,242 -$3,643,758 -14% 31 Oct 2020 10-Q 11 Dec 2020 2020 Q1
Q2 2020 $28,850,728 -$4,348,856 -18% 31 Jul 2020 10-K 29 Oct 2021 2021 FY
Q1 2020 $27,518,704 -$26,207,090 -1998% 30 Apr 2020 10-Q/A 13 Nov 2020 2020 Q3
Q4 2019 $26,519,430 -$25,270,585 -2024% 31 Jan 2020 10-Q/A 13 Nov 2020 2020 Q2
Q3 2019 $25,918,484 -$24,776,112 -2169% 31 Oct 2019 10-Q/A 13 Nov 2020 2020 Q1
Q2 2019 $24,501,872 -$23,428,995 -2184% 31 Jul 2019 10-K 16 Nov 2020 2021 FY
Q1 2019 $1,311,614 -$337,636 -35% 30 Apr 2019 10-Q 07 Jun 2019 2019 Q3
Q4 2018 $1,248,845 -$348,434 -39% 31 Jan 2019 10-Q 14 Mar 2019 2019 Q2
Q3 2018 $1,142,372 -$489,202 -75% 31 Oct 2018 10-Q 13 Mar 2019 2019 Q1
Q2 2018 $1,072,877 -$483,115 -82% 31 Jul 2018 10-K/A 13 Nov 2020 2019 FY
Q1 2018 $973,978 -$419,005 -76% 30 Apr 2018 10-Q 07 Aug 2018 2018 Q3
Q4 2017 $900,411 -$425,450 -90% 31 Jan 2018 10-Q 30 May 2018 2018 Q2
Q3 2017 $653,170 -$209,382 -47% 31 Oct 2017 10-Q 20 Dec 2017 2018 Q1
Q2 2017 $589,762 -$197,844 -50% 31 Jul 2017 10-K 12 Dec 2018 2018 FY
Q1 2017 $554,973 -$199,890 -56% 30 Apr 2017 10-Q 21 Jun 2017 2017 Q3
Q4 2016 $474,961 -$128,062 -37% 31 Jan 2017 10-Q 23 Mar 2017 2017 Q2
Q3 2016 $443,788 -$112,993 -34% 31 Oct 2016 10-Q 20 Dec 2016 2017 Q1
Q2 2016 $391,918 -$86,117 -28% 31 Jul 2016 10-K 14 Nov 2017 2017 FY
Q1 2016 $355,083 30 Apr 2016 10-Q 16 Jun 2016 2016 Q3
Q4 2015 $346,899 31 Jan 2016 10-Q 15 Mar 2016 2016 Q2
Q3 2015 $330,795 31 Oct 2015 10-Q 22 Dec 2015 2016 Q1
Q2 2015 $305,801 -$160,698 -111% 31 Jul 2015 10-K 02 Nov 2016 2016 FY
Q2 2014 $145,103 31 Jul 2014 10-K 01 Dec 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.